Merck Pulls Propecia Information From Their Website

Speculation is growing over whether new warnings will be issued about the risk of Propecia sexual problems, after Merck pulled down their dedicated website for the hair-loss drug earlier this week.

Merck previously had a full website at http://www.Propecia.com, containing information about the popular oral medication designed to treat male pattern baldness.

As of February 8, Merck now displays a message that the propecia.com “website is not currently available”, providing links to the current prescribing information, patient product information, the Propecia Persistence Program and a link encouraging visitors to report any negative side effects of Propecia to the FDA’s MedWatch program.

In recent months, a growing number of men have filed a Propecia lawsuit against Merck, alleging that they are failing to warn about the risk of erectile dysfunction, loss of libido, infertility, anxiety, depression and other sexual problems allegedly caused by Propecia side effects.

The current Propecia warning label indicates that some men have experienced sexual dysfunction after taking the medication, but suggests that the problems are temporary and resolve after men stop using the drug.

Although Merck has been forced to revise the warning label in many other countries, disclosing that post-marketing reports have indicate some men have experienced long-term sexual problems from Propecia, the drug maker has not yet provided similar warnings in the United States.

If new warnings are issued by the drug maker, it is likely that the Propecia litigation will pick up considerable steam, as more men are likely to contact a product liability lawyer after learning about the potential connection between the hair loss drug and their sexual problems.